Arnica Plus DROPS
NDC 66492-245, Aconitum napellus, Arnica montana, Chamomilla, Hypericum perforatum, Ruta graveolens, Symphytum officinale, Belladonna, Colocynthis, Rhus tox, Ferrum phos, Magnesium phos., liquid, from Be Well Medical dba Richard Clement Nutrition y Be Well Homeopathics.
- Product NDC
- 66492-245
- Status
- Listed
- Labeler
- Be Well Medical dba Richard Clement Nutrition y Be Well Homeopathics
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/66492-245 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACONITUM NAPELLUS3 [hp_X]/mL
- ARNICA MONTANA3 [hp_X]/mL
- MATRICARIA RECUTITA3 [hp_X]/mL
- HYPERICUM PERFORATUM3 [hp_X]/mL
- RUTA GRAVEOLENS FLOWERING TOP3 [hp_X]/mL
- COMFREY ROOT3 [hp_X]/mL
- ATROPA BELLADONNA4 [hp_X]/mL
- CITRULLUS COLOCYNTHIS FRUIT PULP4 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF6 [hp_X]/mL
- FERROSOFERRIC PHOSPHATE8 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC8 [hp_X]/mL
Pharmacologic classes
Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 66492-245-02 | 66492024502 | 58.5 mL in 1 BOTTLE, DROPPER (66492-245-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 66492-245 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/66492-245 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 66492-245. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.